NCT07901738Phase 3Not yet recruiting

Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children

Study sponsor: Precigen, Inc · PGEN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-01Estimated
Enrollment · participants15Estimated
Source updated2026-10-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.